openPR Logo
Press release

Prostaglandin E2 Receptor EP4 Subtype - Pipeline Insight and Therapeutic Assessment, H2 2017

08-18-2017 07:57 AM CET | Health & Medicine

Press release from: Healthcare Industry Market Report - MRH

MRH

MRH

Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017” to its report offerings. The report reviews key players involved in Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted therapeutics development with respective active and dormant or discontinued projects.

Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1297804

According to the recently published report 'Prostaglandin E2 Receptor EP4 Subtype Pipeline Review, H2 2017'; Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes.

Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Prostaglandin E2 receptor 4 (EP4) is a prostaglandin receptor encoded by the PTGER4 gene. The activity of the receptor is mediated by G proteins that stimulate adenylate cyclase. It has a relaxing effect on smooth muscle. It plays an important role in regulating renal hemodynamics, intestinal epithelial transport, adrenal aldosterone secretion, and uterine function.

The report 'Prostaglandin E2 Receptor EP4 Subtype Pipeline Review, H2 2017' outlays comprehensive information on the Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.

It also reviews key players involved in Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase II, Phase I and Preclinical stages are 2, 3 and 5 respectively. Similarly, the universities portfolio in Discovery stages comprises 1 molecules, respectively. Report covers products from therapy areas Oncology, Immunology, Central Nervous System, Gastrointestinal, Dermatology, Metabolic Disorders, Respiratory and Women's Health which include indications Autoimmune Disorders, Breast Cancer, Allergies, Chronic Pain, Contact Dermatitis, Inflammatory Bowel Disease, Non-Small Cell Lung Cancer, Osteoarthritis Pain, Bladder Cancer, Cervical Cancer, Chronic Obstructive Pulmonary Disease (COPD), Colorectal Cancer, Endometriosis, Epithelial Ovarian Cancer, Gastrointestinal Tract Cancer, Head And Neck Cancer Squamous Cell Carcinoma, Hepatocellular Carcinoma, Inflammatory Pain, Lung Cancer, Osteoporosis, Pancreatic Cancer, Prostate Cancer, Rectal Cancer, Renal Cell Carcinoma, Rheumatoid Arthritis, Solid Tumor and Ulcerative Colitis.

Scope

- The report provides a snapshot of the global therapeutic landscape for Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4)
- The report reviews Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted therapeutics and enlists all their major and minor projects
- The report assesses Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted therapeutics

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Read Full Report with TOC: http://www.marketresearchhub.com/report/prostaglandin-e2-receptor-ep4-subtype-prostanoid-ep4-receptor-or-ptger4-pipeline-review-h2-2017-report.html

Table of Contents:
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Overview 6
Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Therapeutics Development 7
Products under Development by Stage of Development 7
Products under Development by Therapy Area 8
Products under Development by Indication 9
Products under Development by Companies 12
Products under Development by Universities/Institutes 16
Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Therapeutics Assessment 18
Assessment by Mechanism of Action 18
Assessment by Route of Administration 20
Assessment by Molecule Type 22

Make an Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1297804

About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 1-800-998-4852 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: www.marketresearchhub.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prostaglandin E2 Receptor EP4 Subtype - Pipeline Insight and Therapeutic Assessment, H2 2017 here

News-ID: 673443 • Views: 164

More Releases from Healthcare Industry Market Report - MRH

Global Pressure Relief Mattress Market Analysis, Competitor Analysis, Choice Mod …
The global pressure relief mattress market is growing steadily at a CAGR of 4.63%, owing to rise in demand from individual end-users and healthcare providers, who are looking for better patient care services. Long-term bed-ridden patients in hospitals or in-home care and older adults are more prone to develop pressure ulcers due to lack of mobility. Growing demand for pressure relief mattress from such patients are driving the market growth. Request
Global Hearing Protection Devices Market Segmentation and Analysis by Market Res …
Hearing protection devices are used to protect the human ear from hearing loss due to occupational and other harmful noise. These products reduce noise exposure levels and the risk of hearing loss. These devices have been in existence since the early 1900s, but in the US, the use of these devices in offices and workshops was not controlled by law until 1971. Request A Free Sample Report- http://www.marketresearchhub.com/enquiry.php?type=S&repid=1320831 The Market Research
Global Healthcare Fabrics Sales Market Report : Share, Growth, Size, Trends and …
Market Research Hub (MRH) has recently added a new report to its vast online database. This research study is titled as “Global Healthcare Fabrics Sales Market Report” 2017 which presents an in-depth study about the production, consumption, market volume, revenue (million USD) and market share across different geographical regions. In this report, the global Healthcare Fabrics market is valued at USD XX million in 2016 and is expected to
Vacation Animal Health Market Analysis, Outlook and Forecast Report Until 2021
Market Research Hub (MRH) has included the latest Forecast report titled “Vacation Animal Health Market Industry Analysis & Outlook (2017-2021)”, to its vast database. The report provides a comprehensive analysis of the global animal health market and its major regional markets. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in-depth. Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1318871 Animals, like humans, also suffer from diseases and hence require

All 5 Releases


More Releases for EP4

Canine Arthritis Market: How the Market will perform in Upcoming Years based on …
Canine arthritis is a major ailments seen in the middle aged to older dogs. Most common causes of canine arthritis include, cartilage deficits, previous injuries such as anterior cruciate ligament, poor nutrition, trauma after a car accident, penetration of joint by a sharp object, or bite, infection in the joint, stresses on the joint, disruption of cartilage, bone, synovial membranes, and ligaments that support a joint, bacteria spread through the
Canine Arthritis Market to Witness Increased Revenue Growth Owing to Rapid Incre …
Canine arthritis is a major ailments seen in the middle aged to older dogs. Most common causes of canine arthritis include, cartilage deficits, previous injuries such as anterior cruciate ligament, poor nutrition, trauma after a car accident, penetration of joint by a sharp object, or bite, infection in the joint, stresses on the joint, disruption of cartilage, bone, synovial membranes, and ligaments that support a joint, bacteria spread through the
Bio-Lubricants Market | Growth, Trends and Forecasts 2022 by Total S.A, Exxon Mo …
Global Bio-Lubricants Market – Overview With an increasing level of impetus placed on environmentally safe products, Bio Lubricants are being manufactured to address the problems associated with using other forms of lubricants. They are highly popular and are easily manufactured by the use of vegetable oils such as soya bean, coconut, canola and rapeseed etc. Market Research Future, who specializes in reports related to chemicals and materials recently stated in a
Bio-lubricants Market Share 2018 to 2022, Top Players - Total S.A, Exxon Mobil, …
Global Bio-Lubricants Market – Overview With an increasing level of impetus placed on environmentally safe products, Bio Lubricants are being manufactured to address the problems associated with using other forms of lubricants. They are highly popular and are easily manufactured by the use of vegetable oils such as soya bean, coconut, canola and rapeseed etc. Market Research Future, who specializes in reports related to chemicals and materials recently stated in a
Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) – Pi …
ReportsWorldwide has announced the addition of a new report title Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) – Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary According to the recently published report 'Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H2 2017'; Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) pipeline Target constitutes close to 11 molecules. Out of which approximately
Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) – Pi …
ReportsWorldwide has announced the addition of a new report title Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) – Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary According to the recently published report 'Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H2 2017'; Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) pipeline Target constitutes close to 11 molecules. Out of which approximately